◆英語タイトル:Bioprognos SL - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C12763
◆発行会社(調査会社):
GlobalData
◆発行日:2018年12月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Bioprognos SL (Bioprognos) is a cancer diagnostics company that develops non-invasive and accurate diagnostics solutions. The company’s pipeline products include OncoBREAST Dx, OncoLUNG Dx, OncoOVARIAN Dx, OncoPROSTATE Dx, OncoCUP Dx, OncoLIVER Dx, OncoNECK Dx, OncoBLADDER Dx, and OncoCOLON Dx. It offers IOTA’s tests and ACR’s tests. Bioprognos also develops multiple biomarkers disease activity algorithms (MBDAA) for the detection of various neoplasia associated biomarkers body fluids. The company’s products are used for the diagnosis of bladder, breast, colorectal, gastric, head and neck, kidney, liver, lungs, ovarian, pancreatic, prostate, testicular, oesophageal, and thyroid cancer. Bioprognos is headquartered in Barcelona, Spain.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Bioprognos SL
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Bioprognos SL Company Overview 4
Bioprognos SL Company Snapshot 4
Bioprognos SL Pipeline Products and Ongoing Clinical Trials Overview 4
Bioprognos SL – Pipeline Analysis Overview 6
Bioprognos SL – Key Facts 6
Bioprognos SL – Major Products and Services 7
Bioprognos SL Pipeline Products by Development Stage 8
Bioprognos SL Pipeline Products Overview 10
MBDAA Colorectal Cancer Test 10
MBDAA Colorectal Cancer Test Product Overview 10
MBDAA Gallbladder Cancer Test 11
MBDAA Gallbladder Cancer Test Product Overview 11
MBDAA Gastric Cancer Test 12
MBDAA Gastric Cancer Test Product Overview 12
MBDAA Liver Cancer Test 13
MBDAA Liver Cancer Test Product Overview 13
MBDAA Pancreatic Cancer Test 14
MBDAA Pancreatic Cancer Test Product Overview 14
MBDAA Thyroid Cancer Test 15
MBDAA Thyroid Cancer Test Product Overview 15
Bioprognos SL – Key Competitors 16
Bioprognos SL – Key Employees 17
Bioprognos SL – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 22
Contact Us 22
Disclaimer 22
List of Tables
Bioprognos SL Pipeline Products and Ongoing Clinical Trials Overview 4
Bioprognos SL Pipeline Products by Equipment Type 5
Bioprognos SL Pipeline Products by Indication 5
Bioprognos SL, Key Facts 6
Bioprognos SL, Major Products and Services 7
Bioprognos SL Number of Pipeline Products by Development Stage 8
Bioprognos SL Pipeline Products Summary by Development Stage 9
MBDAA Colorectal Cancer Test - Product Status 10
MBDAA Colorectal Cancer Test - Product Description 10
MBDAA Gallbladder Cancer Test - Product Status 11
MBDAA Gallbladder Cancer Test - Product Description 11
MBDAA Gastric Cancer Test - Product Status 12
MBDAA Gastric Cancer Test - Product Description 12
MBDAA Liver Cancer Test - Product Status 13
MBDAA Liver Cancer Test - Product Description 13
MBDAA Pancreatic Cancer Test - Product Status 14
MBDAA Pancreatic Cancer Test - Product Description 14
MBDAA Thyroid Cancer Test - Product Status 15
MBDAA Thyroid Cancer Test - Product Description 15
Bioprognos SL, Key Employees 17
Glossary 21
List of Figures
Bioprognos SL Pipeline Products by Equipment Type 5
Bioprognos SL Pipeline Products by Development Stage 8